Skip to main content
Blog , Careers

Colleague Stories: Dr. Asma Patel

Get to know the people behind Quotient Sciences in our colleague Q&A series. 

What’s your current role at Quotient Sciences?

I’m currently Vice President, Global Commercial and Scientific Consulting – Drug Product. In this role, I lead the drug product commercial, scientific consulting, and proposals teams. I work very closely with clients as well as internal scientific and operational teams to shape development strategies. What I enjoy most is helping clients understand how Quotient Sciences' science, people, and integrated capabilities can come together to solve complex drug product challenges and ultimately support better decision‑making and successful programs.

How did your career journey here begin?

I joined Quotient Sciences 17 years ago as a bench formulation scientist, working hands‑on in the lab on drug product development. Those early years were all about learning the fundamentals, troubleshooting real formulation challenges, and understanding how development decisions impact projects downstream. That strong grounding in practical science has shaped everything I’ve gone on to do since and continues to influence how I approach leadership, strategy, and client conversations today.

What roles or career moves have you made since joining?

Over the years, I’ve progressed through a wide range of roles across the organization. I started in scientific roles as a Formulation Scientist, Senior Formulation Scientist, and Principal Formulation Scientist, before moving into technical operational leadership roles including Director and Senior Director of Development. From there, I transitioned into more commercial‑facing leadership roles, including Executive Director, Product Development, VP Integrated Development Services, and now my current role. Each move allowed me to build on my technical foundation while taking on broader responsibility across project leadership, people management, client engagement, and strategic consulting, combining deep science with a strong external and commercial focus.

What have you enjoyed most about your career at Quotient Sciences?

The variety and the people. I’ve had the opportunity to work across different technologies, therapeutic areas, client challenges, and teams, which has kept my work interesting and continually evolving. I’ve also been very lucky to work alongside many talented, supportive colleagues over the years. Quotient Sciences has allowed me to grow, change direction, and develop new skills without having to leave the organization, which isn’t something everyone gets to experience.

What’s one achievement you’re proud of?

I’m particularly proud of successfully transitioning from a purely technical role into a senior leadership and client‑facing position, while still staying closely connected to the science. Being able to use my technical background to add value in strategic discussions, while also mentoring and developing others, has been very rewarding and something I’m genuinely proud of.

What’s helped you progress or develop the most?

Being open to new opportunities and willing to step outside my comfort zone has made a huge difference. I’ve also benefited from having supportive managers, mentors, and teams who have encouraged me to take on new challenges. Quotient Sciences has consistently invested in my development and trusted me with increasing responsibility, which has played a big part in my growth.

What advice would you give to someone wanting to progress their career at Quotient Sciences?

Be curious, speak up about your ambitions, and don’t be afraid to try something new. Careers don’t always follow a straight line, and there are many different paths available at Quotient Sciences. Taking opportunities, even when they feel a bit uncomfortable at first, can open doors you might not have expected!

What I enjoy most is helping clients understand how Quotient Sciences' science, people, and integrated capabilities can come together to solve complex drug product challenges and ultimately support better decision‑making and successful programs.
– Dr. Asma Patel

Drug development questions? Let's talk.
Humanity can't afford to wait, so neither can we.